Walmsley says GSK is “incredibly intentional” in how the company recruits and trains talent. The company’s management has ...

GSK CEO Emma Walmsley’s $13 million salary is predicated on picking the right people to steer cutting-edge drug development for the world’s most challenging diseases. During her eight years at ...

GlaxoSmithKline (GSK) has appointed its consumer health leader, Emma Walmsley, to take over as CEO when Sir Andrew Witty retires next year. Walmsley has a background in marketing, and joined GSK ...

Explore how U.S. tariffs and vaccine skepticism may impact GSK plc's profitability. Click for my update as tariffs are ...

GSK could double its long-serving CEO Emma Walmsley’s pay packet to £21.6 million ($27.2 million) after admitting its boss's current pay didn’t reward her performance and would put off future ...

GlaxoSmithKline’s new CEO Emma Walmsley is set to outline ... MaxiNutrition sports nutrition brand. Bought by GSK under the leadership of Walmsley’s predecessor, Sir Andrew Witty, the business ...

GSK, led by boss Emma Walmsley (pictured), is using the data of 1.4m adults aged 65 and 66 to examine the impact of its ...

GSK is betting on AI to boost innovation for ... but a balanced approach toward regulation is important, CEO Emma Walmsley says. Speaking at the CEO Times Summit in London, Walmsley highlights ...

British pharma giant GSK’s Emma Walmsley navigated setbacks during the COVID-19 pandemic and looming activist investors, among other things, to create new growth engines in cancer treatments and ...

Now that its hand has been revealed, there is no question that Unilever will do its best to acquire the consumer division of GlaxoSmithKline as it completes its demerger. Its £50bn offer may rise ...